Search Results - Howard Burris

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update by Aaron Scott, Manish Patel, Julie Bauman, Jeffrey Clarke, Howard Burris, Justin Gainor, Martin Gutierrez, Daniel Cho, Ricklie Julian, Pamela Cohen, Joshua Frederick, Celine Robert-Tissot, Honghong Zhou, Kinjal Mody, Karen Keating, Robert Meehan

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  2. 2

    P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B DOSE ESCALATION STUDY IN RELAPSE-REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASIA by Ewa Lech-Marańda, Agata Szymańska, Jan Zaucha, Gautam Borthakur, Scott Solomon, Terrence Bradley, Elie Mouhayar, Noemi Angelosanto, Hendrik Nogai, Krzysztof Brzozka, Tomasz Rzymski, Peter Littlewood, Kamil Kus, Renata Dudziak, Axel Glasmacher, Howard Burris, Camille Abboud

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    A prospective outcomes and cost-effective analysis of surgery compared to stereotactic body radiation therapy for stage I non-small cell lung cancer by Andrew Kennedy, Shanna A. Arnold Egloff, Casey Martin, Denis Gilmore, Susan Garwood, Tammy Baxter, David Spigel, Melissa Johnson, David Randolph II, Casey Chollet-Lipscomb, Laurie Cuttino, Eleanor Osborne, Jenifer Marks, Pratik Doshi, Meredith Mattlin, Richard Geer, Dax Kurbegov, Howard Burris III

    Published in Radiation Oncology (2025-08-01)
    Get full text
    Article


  4. 4

    Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies by Aung Naing, Jeffrey Infante, Sanjay Goel, Howard Burris, Chelsea Black, Shannon Marshall, Ikbel Achour, Susannah Barbee, Rena May, Chris Morehouse, Kristen Pollizzi, Xuyang Song, Keith Steele, Nairouz Elgeioushi, Farzana Walcott, Joyson Karakunnel, Patricia LoRusso, Amy Weise, Joseph Eder, Brendan Curti, Michael Oberst

    Published in Journal for ImmunoTherapy of Cancer (2019-08-01)
    Get full text
    Article


Search Tools: